https://www.selleckchem.com/pr....oducts/atezolizumab.
001 each). Among group I patients at cut-off 12.4, up-regulation of platelet CD62P yielded 72% sensitivity and 44.1% specificity to discriminate bleeders from non-bleeders ( = 0.01), while among group II at cut-off 12.9, it yielded 90% sensitivity and 80.8% specificity ( 0.001). In cirrhotic patients, platelet CD62P expression was significantly increased in patients with an advanced Child-Pugh class ( 0.001). Platelet expressing CD62P was shown as an independent risk factor for bleeding among cirrhotic cases wit
Like
Comment
Share
